Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma

被引：0
|
作者：
Leanne Kaye
Vy Vuong
Meredith A. Barrett
Elroy Boers
Theresa Guilbert
机构：
[1] ResMed Science Center,Department of Pediatrics
[2] ResMed Science Center,undefined
[3] University of Cincinnati and Pulmonary Division,undefined
[4] Cincinnati Children’s Hospital Medical Center,undefined
来源：
npj Primary Care Respiratory Medicine | / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Significant indirect healthcare costs are related to uncontrolled asthma, including productivity loss. Days with short-acting beta-agonist (SABA) use is associated with symptom-related disruptions at work, home, and school. Digital self-management platforms may support fewer days with SABA medication use and may reduce symptom-related disruptions.
引用
收藏
相关论文
共 50 条
  • [21] Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase
    Shlomi, Dekel
    Katz, Irit
    Segel, Michael J.
    Oberman, Bernice
    Peled, Nir
    [J]. JOURNAL OF ASTHMA, 2018, 55 (05) : 571 - 577
  • [22] Identification of asthma level of control using administrative data of short-acting beta-agonist inhalers purchase
    Shlomi, Dekel
    Katz, Irit
    Segal, Michael
    Peled, Nir
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [23] The Relationship Between Self-Reported Productivity and Digitally-Captured Short-Acting Beta-Agonist (SABA) Use in Asthma
    Kaye, L.
    Vuong, V.
    Barrett, M. A.
    Boers, E.
    Guilbert, T. W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [24] Association Between Objective Short-Acting Beta-Agonist Use and Self-Reported Asthma Control Test Scores Among Adults with Asthma
    Anderson, W. C.
    Hoch, H.
    Kaye, L.
    Tuffli, M.
    Barrett, M.
    Van Sickle, D.
    Szefler, S. J.
    Stempel, D. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [25] The effect of rescue short-acting beta-agonist bronchodilation in patients on Montelukast or Salmeterol
    Storms, WW
    Bird, S
    Firriolo, KM
    Edelman, JM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S316 - S316
  • [26] Prediction of short-acting beta-agonist usage in patients with asthma using temporal-convolutional neural networks
    Hirons, Nicholas
    Allen, Angier
    Matsuyoshi, Noah
    Su, Jason
    Kaye, Leanne
    Barrett, Meredith A.
    [J]. JAMIA OPEN, 2023, 6 (04)
  • [27] REAL-WORLD PATTERNS AND IMPLICATIONS OF SHORT-ACTING BETA-AGONIST USE AMONG PATIENTS WITH COPD
    Lugogo, Njira
    Gilbert, Ileen
    Goshi, Nadia
    Gandhi, Hitesh
    Surmont, Filip
    Moore-Schiltz, Laura
    Tkacz, Joseph
    Barjaktarevic, Igor
    [J]. CHEST, 2020, 158 (04) : 1742A - 1744A
  • [28] The Association of Digitally Collected Short-Acting Beta-Agonist and Maintenance Medication Use and COPD Assessment Test
    Gondalia, R.
    Theye, B.
    Stempel, D. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [29] Pregnancy Outcomes According to Long- and Short-Acting Beta-Agonist Use: The Asthma Medications in Pregnancy Surveillance System Cohort Arm
    Palmsten, Kristin
    Luo, Yunjun
    Johnson, Diana L.
    Schatz, Michael
    Chambers, Christina D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 412 - 413
  • [30] Short-Acting β-Agonist Use As a Marker of Current Asthma Control
    Patel, Mitesh
    Pilcher, Janine
    Munro, Claire
    Hosking, Alexander
    Pritchard, Alison
    Shaw, Dominick
    Black, Peter
    Weatherall, Mark
    Beasley, Richard
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (04): : 370 - 377
12345